Liu Z - Search Results

1

DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity.

Lu C, Guan J, Lu S, Jin Q, Rousseau B, Lu T, Stephens D, Zhang H, Zhu J, Yang M, Ren Z, Liang Y, Liu Z, Han C, Liu L, Cao X, Zhang A, Qiao J, Batten K, Chen M, Castrillon DH, Wang T, Li B, Diaz LA Jr, Li GM, Fu YX. Lu C, et al. Among authors: liu z, liu l. Cancer Cell. 2021 Jan 11;39(1):96-108.e6. doi: 10.1016/j.ccell.2020.11.006. Epub 2020 Dec 17. Cancer Cell. 2021. PMID: 33338425 Free PMC article.

2

Targeting innate sensing in the tumor microenvironment to improve immunotherapy.

Liu Z, Han C, Fu YX. Liu Z, et al. Cell Mol Immunol. 2020 Jan;17(1):13-26. doi: 10.1038/s41423-019-0341-y. Epub 2019 Dec 16. Cell Mol Immunol. 2020. PMID: 31844141 Free PMC article. Review.

3

Chemotherapy Induces Cancer-Fighting B Cells.

Liu Z, Fu YX. Liu Z, et al. Cell. 2020 Mar 19;180(6):1037-1039. doi: 10.1016/j.cell.2020.02.046. Epub 2020 Mar 5. Cell. 2020. PMID: 32142652 Free article.

4

Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling.

Han C, Liu Z, Zhang Y, Shen A, Dong C, Zhang A, Moore C, Ren Z, Lu C, Cao X, Zhang CL, Qiao J, Fu YX. Han C, et al. Among authors: liu z. Nat Immunol. 2020 May;21(5):546-554. doi: 10.1038/s41590-020-0641-5. Epub 2020 Mar 30. Nat Immunol. 2020. PMID: 32231300

5

Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy.

Han C, Zhang A, Liu Z, Moore C, Fu YX. Han C, et al. Among authors: liu z. Oncogene. 2021 Feb;40(5):885-898. doi: 10.1038/s41388-020-01575-7. Epub 2020 Dec 7. Oncogene. 2021. PMID: 33288883 Review.

6

Adapting conventional cancer treatment for immunotherapy.

Qiao J, Liu Z, Fu YX. Qiao J, et al. Among authors: liu z. J Mol Med (Berl). 2016 May;94(5):489-95. doi: 10.1007/s00109-016-1393-4. Epub 2016 Feb 24. J Mol Med (Berl). 2016. PMID: 26910191 Review.

7

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX. Ren Z, et al. Among authors: liu z, liu x. Clin Cancer Res. 2017 Jan 1;23(1):193-203. doi: 10.1158/1078-0432.CCR-16-0040. Epub 2016 Jun 27. Clin Cancer Res. 2017. PMID: 27354469 Free PMC article.

8

Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8⁺ T Cell Apoptosis.

Qiao J, Liu Z, Dong C, Luan Y, Zhang A, Moore C, Fu K, Peng J, Wang Y, Ren Z, Han C, Xu T, Fu YX. Qiao J, et al. Among authors: liu z. Cancer Cell. 2019 Jun 10;35(6):901-915.e4. doi: 10.1016/j.ccell.2019.05.005. Cancer Cell. 2019. PMID: 31185213 Free article.

9

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance.

Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, Boothman DA, Qiao J, Wang Y, Huang X, Fu YX. Li X, et al. Among authors: liu z. Nat Commun. 2019 Jul 19;10(1):3251. doi: 10.1038/s41467-019-11238-1. Nat Commun. 2019. PMID: 31324798 Free PMC article.

10

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.

Liu Z, Han C, Dong C, Shen A, Hsu E, Ren Z, Lu C, Liu L, Zhang A, Timmerman C, Pu Y, Wang Y, Chen M, Qiao J, Fu YX. Liu Z, et al. Among authors: liu l. Sci Immunol. 2019 Aug 9;4(38):eaav6473. doi: 10.1126/sciimmunol.aav6473. Sci Immunol. 2019. PMID: 31399492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,657 results

Search Page